// App-Quantinova.ai

: Anticoagulation Management and Outcomes in Thrombocytopenic Cancer Patients with Atrial Fibrillation

Researchers

Presenter

  • N. Livneh

Principal Investigators

  • D. Braeken

  • G. Drozdinsky

  • A. Gafter-Gvili

  • J. Seelig

  • U. Rozovski

  • P. Raanani

  • A. Falanga

  • H. ten Cate

  • G. Spectre

  • A. Leader

Medical Centers

  • Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel

  • Maastricht University Medical Center, Thrombosis Expert Center, Maastricht, the Netherlands

  • Rabin Medical Center, Internal Medicine A, Petah Tikva, Israel

  • Rabin Medical Center, Internal Medicine A, Petah Tikva, Israel

  • Rabin Medical Center, Davidoff Cancer Center, Institute of Hematology, Petah Tikva, Israel

  • Hospital Rijnstate, Department of Cardiology, Arnhem, the Netherlands

  • Hospital Papa Giovanni XXIII, Immunohematology and Transfusion Medicine Department, Bergamo, Italy

  • Maastricht University, Cardiovascular Research Institute, Maastricht, the Netherlands

Locations

  • Israel

  • Netherlands

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Pulmonary/Respiratory Diseases

  • Central Nervous System (CNS)

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Transient Ischemic Attack

  • Arrhythmia

  • Thrombocytopenia

  • Ischemic stroke

  • Venous thrombosis

  • Solid malignancies

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved